CATECHOLAMINES IN AGING AND OXIDATIVE STRESS
儿茶酚胺在衰老和氧化应激中的作用
基本信息
- 批准号:7092790
- 负责人:
- 金额:$ 19.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs diseaseCyanophytaagingangiospermsantioxidantsassociation learningbacterial proteinscatecholaminescerebellumdiet therapydietary supplementsfruitgenetically modified animalslaboratory mousemitochondrianeurogeneticsneuropharmacologyneuroprotectantsnonhuman therapy evaluationnutrition related tagoxidative stresspremature agingtumor necrosis factor alphavegetables
项目摘要
Oxidative stress and inflammation have been proposed to play key roles in aging and
neurodegenerative diseases associated with aging such Alzheimer's disease and Parkinson's disease.
Thus, an understanding of the mechanisms in the brain that leads to an increase in inflammation and
oxidative stress could lead to rational therapeutic interventions in aging and neurodegenerative diseases.
We have been examining nutritional interventions such as spinach or blueberries, which lead to
improvements in learning and memory in aged rats and modulation of many biomarkers of brain aging. In
the past granting period, we have demonstrated that inflammation and oxidative stress occur in the aged
brain and that these processes may contribute to the declines in cognitive function. We have
demonstrated that both natural and pharmaceutical antioxidant and anti-inflammatory agents are capable
of improving cognitive deficits in aged rats and this is concomitant with changes in neuronal signal
transduction. We will examine potential mechanisms by which these diets alter brain aging. One potential
mechanism is an amelioration of an increase in inflammation with age. Microglial cells are an important
source of reactive oxygen species (ROS) in the brain as well as other inflammatory signals such as proinflammatory
cytokines and therefore may play a central role in modulating CNS oxidative stress and
neurodegenerative diseases. We plan to investigate immune function in the progression of
neurodegeneration in the aged brain and the potential for therapeutic intervention in neurodegenerative
diseases such as Alzheimer's disease. We hypothesize that oxidative stress and inflammation are
primary drivers of neuronal dysfunction in the aged brain; furthermore, age-related changes in microglia
are the critical primary events in brain aging and neurodegenerative disease. Specifically, in the
cerebellum, microglial production of tumor necrosis factor (TNF)alpha leads to further inflammation and
oxidative stress. Therapeutic interventions that reduce TNFalpha and/or microglial activation will
improve neuronal function and concomitantly learning and memory in aged animals will be
improved.
氧化应激和炎症被认为在衰老和衰老过程中起关键作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAULA C BICKFORD其他文献
PAULA C BICKFORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAULA C BICKFORD', 18)}}的其他基金
Aging and Innate immune system resilience in TBI
TBI 中的衰老和先天免疫系统恢复能力
- 批准号:
10616497 - 财政年份:2022
- 资助金额:
$ 19.35万 - 项目类别:
Aging and Innate immune system resilience in TBI
TBI 中的衰老和先天免疫系统恢复能力
- 批准号:
10369760 - 财政年份:2022
- 资助金额:
$ 19.35万 - 项目类别:
ShEEP Request for QuantStudio 12K Flex Real-Time PCR system
ShEEP 请求 QuantStudio 12K Flex 实时 PCR 系统
- 批准号:
9796289 - 财政年份:2019
- 资助金额:
$ 19.35万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10618267 - 财政年份:2018
- 资助金额:
$ 19.35万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10265423 - 财政年份:2018
- 资助金额:
$ 19.35万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
9899096 - 财政年份:2018
- 资助金额:
$ 19.35万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10454209 - 财政年份:2018
- 资助金额:
$ 19.35万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 19.35万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 19.35万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 19.35万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 19.35万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 19.35万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 19.35万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 19.35万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 19.35万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 19.35万 - 项目类别:














{{item.name}}会员




